Quoin Pharmaceuticals (NASDAQ:QNRX) focuses primarily on developing innovative treatments for rare and serious diseases. This company, with its dedication to addressing unmet medical needs, is active in various stages of research and development. Quoin Pharmaceuticals' portfolio includes projects aimed at tackling conditions that currently lack sufficient treatment options, highlighting its commitment to improving patient outcomes. Their objective is not just to advance healthcare but to revolutionize it by bringing forward novel therapies that can significantly impact people's lives. Quoin Pharmaceuticals trades exclusively on the NASDAQ stock exchange under the ticker symbol QNRX, reflecting its position within the global financial market and highlighting its accessibility to investors interested in contributing to healthcare advancements.